Jinlin University
Also known as: department of generay surgery, jinling hospital | Department of Generay Surgery, Jinling hosptal | Department of Neurology, Jinling Hospital, China | Director of gastroenterology Department, Jinling Hospital | Jianfeng Gong | Jiang Wu | Jinling Hospital | Jinling Hospital Affiliated to c University | Jinling Hospital, China | Jinling Hosptial | Shengxian Fan | Shi Jinyun | The First Hospital of Jilin University | the First Hospital of Jinlin University | The First Hospital of Jinlin University | The Jinling Hospital | Xinfeng Liu | Yongping Zhai | Zhu Weiming
Highest phase reached
Phase 4
First clinical trial
Jul 1, 2007Last known activity
Apr 30, 2026
Timeline
1920s
- Jan 1, 1929
Jinlin University— Founded
Drugs by trial phase (223 distinct, 206 trials)
Phase 4 (28 own, 0 via acquisition)
Phase 3 (36 own, 0 via acquisition)
Phase 2 (62 own, 0 via acquisition)
Phase 1 (50 own, 0 via acquisition)
Other trials (47 own, 0 via acquisition)
Indications
Studied for
- Amyloidosis
- Azoospermia
- Breast Neoplasms
- Cerebral Infarction
- Cerebrovascular Disorders
- Clostridium Infections
- Colitis
- Colitis, Ulcerative
- Constipation
- Constriction, Pathologic
- Crohn Disease
- Depression
- Depressive Disorder
- Digestive System Diseases
- Fecal Impaction
- Fistula
- Gastrointestinal Diseases
- Gastrointestinal Neoplasms
- Glomerulonephritis, Membranous
- Hyperphosphatemia
- Ileus
- Immunoglobulin Light-chain Amyloidosis
- Infections
- Inflammatory Bowel Diseases
- Insulin Resistance
- Intestinal Diseases
- Intestinal Fistula
- Intraabdominal Infections
- Ischemia
- Kidney Diseases
- Leukemia
- Leukemia, Large Granular Lymphocytic
- Lymphoma
- Lymphoma, B-Cell
- Lymphoma, Large B-Cell, Diffuse
- Major Depressive Disorder
- Multiple Myeloma
- Neoplasms, Plasma Cell
- Pancreatitis
- Pancreatitis, Acute Necrotizing
- Postoperative Complications
- Psoriasis
- Sepsis
- Short Bowel Syndrome
- Stomach Neoplasms
- Stroke
- Syndrome
- Thrombocytopenia
- Ulcer
Recent trials (50)
- NCT07309380OfficialPhase 3Apr 30, 2026
- NCT07305896Lead sponsorN/ADec 31, 2025
- NCT07230301Sponsor investigatorPhase 2Nov 30, 2025
- NCT07230301Lead sponsorPhase 2Nov 30, 2025
- NCT07246304CollaboratorEarly Phase 1Nov 30, 2025
- NCT07207681Sponsor investigatorPhase 1Oct 15, 2025
- NCT07207681Lead sponsorPhase 1Oct 15, 2025
- NCT07157631CollaboratorN/ASep 29, 2025
- NCT07210996OfficialPhase 1Sep 12, 2025
- NCT07179913OfficialPhase 4Sep 10, 2025
- NCT07179913Sponsor investigatorPhase 4Sep 10, 2025
- NCT07179913Lead sponsorPhase 4Sep 10, 2025
- NCT07030894Lead sponsorPhase 4Sep 1, 2025
- NCT07137910OfficialPhase 2Aug 27, 2025
- NCT07067775OfficialPhase 1Aug 5, 2025
Details
- Founded
- Nanjing, CN Jan 1, 1929
- Last known activity
- Apr 30, 2026
Notes
--- Pre-folding founded info: None None None None None ---